《Npj Precision Oncology》雜志的最新年發文量為130篇。
這表明該刊在每年都會精選并發表一定數量的高質量文章，以保持其在腫瘤學領域的學術影響力。
該刊聚焦于醫學-腫瘤學領域的前沿研究，致力于推動該領域新技術和新知識的傳播與應用。同時它積極鼓勵研究人員詳細發表其高質量的實驗研究和理論成果。
該刊的平均審稿周期約為 18 Weeks 。
Npj Precision Oncology 雜志發文統計
文章名稱引用次數
- Organotropism: new insights into molecular mechanisms of breast cancer metastasis30
- Role of nonresolving inflammation in hepatocellular carcinoma development and progression28
- Deep sequencing of circulating exosomal microRNA allows non-invasive glioblastoma diagnosis28
- Vitamin C preferentially kills cancer stem cells in hepatocellular carcinoma via SVCT-226
- Interaction between Wnt/beta-catenin and RAS-ERK pathways and an anti-cancer strategy via degradations of beta-catenin and RAS by targeting the Wnt/beta-catenin pathway23
- Cardiotoxicity with vascular endothelial growth factor inhibitor therapy22
- Tumor evolution and chemoresistance in ovarian cancer20
- CRISPR/Cas9 - An evolving biological tool kit for cancer biology and oncology17
- A transcriptional MAPK Pathway Activity Score (MPAS) is a clinically relevant biomarker in multiple cancer types13
- Artificial intelligence for precision oncology: beyond patient stratification12
國家/地區發文量
- USA58
- CHINA MAINLAND22
- Australia5
- Canada5
- Japan3
- Singapore3
- South Korea3
- Spain3
- Sweden3
- Austria2
